Evidence map›Paper›PMID 40076804›Full record

ArticleInternational journal of molecular sciences2025

Novel Cell Models to Study Myelin and Microglia Interactions.

Marta Santacreu-Vilaseca, Judith Moreno-Magallon, Alba Juanes-Casado, Anna Gil-Sánchez, Cristina González-Mingot, Pascual Torres, Luis Brieva

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marta Santacreu-VilasecaMetabolic Pathophysiology Research Group, Department of Experimental Medicine, University of Lleida-IRBLleida, 25198 Lleida, Spain.
Judith Moreno-MagallonNeuroimmunology Group, Department of Medicine, University of Lleida-IRBLleida, 25198 Lleida, Spain.ORCID 0009-0006-6394-3323
Alba Juanes-CasadoMetabolic Pathophysiology Research Group, Department of Experimental Medicine, University of Lleida-IRBLleida, 25198 Lleida, Spain.
Anna Gil-SánchezNeuroimmunology Group, Department of Medicine, University of Lleida-IRBLleida, 25198 Lleida, Spain.ORCID 0000-0002-0738-5578
Cristina González-MingotNeuroimmunology Group, Department of Medicine, University of Lleida-IRBLleida, 25198 Lleida, Spain.ORCID 0000-0002-6387-8764
Pascual TorresMetabolic Pathophysiology Research Group, Department of Experimental Medicine, University of Lleida-IRBLleida, 25198 Lleida, Spain.ORCID 0000-0001-7903-3478
Luis BrievaNeuroimmunology Group, Department of Medicine, University of Lleida-IRBLleida, 25198 Lleida, Spain.ORCID 0000-0002-5871-6189

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple sclerosis (MS) is characterized by demyelination and neuroinflammation, with oxidative stress playing a pivotal role in lesion pathology. This study aimed to investigate the differential cellular responses to myelin debris under varying oxidative states. Myelin oxidation was induced using a Cu-peroxide system, confirmed by elevated TBARS levels and autofluorescence. BV-2 microglia viability remained unaffected by myelin exposure. However, oxidized myelin significantly altered oxidative stress markers, autophagy, and iron metabolism, as evidenced by changes in Sod2, Tfr1, p62, and P-Erk/Erk ratios. Morphological analyses revealed time- and dose-dependent differences in myelin processing, with oxidized myelin leading to distinct phagosome dynamics. Complementary studies using induced microglia-like cells (iMG)-a primary cell culture-confirmed the feasibility of employing oxidized microglia to study microglia activity. The use of iMGs provides a model closer to patient physiology, offering the potential to evaluate individual cellular responses to oxidative damage. This approach could be instrumental in identifying personalized therapeutic strategies by assessing patient-specific microglial behavior in response to myelin debris. These findings highlight the impact of myelin oxidative status on microglial function, advancing the understanding of oxidative stress in MS and paving the way for personalized medicine applications in neuroinflammation.

Indexed as

MicrogliaMyelin SheathAnimalsAutophagyCell LineMiceMultiple SclerosisOxidation-ReductionOxidative Stressdemyelinationmicrogliamultiple sclerosisneurodegenerationoxidative stresspersonalized medicineprimary cell culture

Identifiers

PMID40076804
PMCPMC11900003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.